Search research articles
Contact Us
Filters
Showing results (201-210 of 231) with videos related to
Page
of 24
Sort By:
Zhonghua Nei Ke Za Zhi
|
April 1, 2016
[The prevalence and etiology of anemia in urban community dwelling elderly population in Beijing]
S Y Ning, N B Chang, X Y Han, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
M D Berger, S Stintzing, V Heinemann, et al.
Human Genetics
|
January 24, 1998
Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities
E Schröck, T Veldman, H Padilla-Nash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
W Zhang, T Winder, Y Ning, et al.
Plos Medicine
|
June 30, 2011
Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study
Steven Riley, Kin O Kwok, Kendra M Wu, et al.
The Pharmacogenomics Journal
|
October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim, W Zhang, T Wakatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
M Suenaga, M Schirripa, S Cao, et al.
Leukemia
|
October 30, 2013
Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy
A Thakurta, A K Gandhi, M F Waldman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2014
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer
Y Sunakawa, S Stremitzer, S Cao, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 231) with videos related to
Sort By:
Page
of 24
Zhonghua Nei Ke Za Zhi
|
April 1, 2016
[The prevalence and etiology of anemia in urban community dwelling elderly population in Beijing]
S Y Ning, N B Chang, X Y Han, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
M D Berger, S Stintzing, V Heinemann, et al.
Human Genetics
|
January 24, 1998
Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities
E Schröck, T Veldman, H Padilla-Nash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2010
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
W Zhang, T Winder, Y Ning, et al.
Plos Medicine
|
June 30, 2011
Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study
Steven Riley, Kin O Kwok, Kendra M Wu, et al.
The Pharmacogenomics Journal
|
October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim, W Zhang, T Wakatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
M Suenaga, M Schirripa, S Cao, et al.
Leukemia
|
October 30, 2013
Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy
A Thakurta, A K Gandhi, M F Waldman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2014
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer
Y Sunakawa, S Stremitzer, S Cao, et al.
Page
of 24